Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;9(3):229-238.
doi: 10.1177/2048872620924613. Epub 2020 May 7.

Respiratory Management in Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Affiliations
Free PMC article

Respiratory Management in Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Susanna Price et al. Eur Heart J Acute Cardiovasc Care. .
Free PMC article

Abstract

The severe acute respiratory syndrome coronavirus 2 pandemic is to date affecting more than a million of patients and is challenging healthcare professionals around the world. Coronavirus disease 2019 may present with a wide range of clinical spectrum and severity, including severe interstitial pneumonia with high prevalence of hypoxic respiratory failure requiring intensive care admission. There has been increasing sharing experience regarding the patient's clinical features over the last weeks which has underlined the need for general guidance on treatment strategies. We summarise the evidence existing in the literature of oxygen and positive pressure treatments in patients at different stages of respiratory failure and over the course of the disease, including environment and ethical issues related to the ongoing coronavirus disease 2019 infection.

Keywords: Severe acute respiratory syndrome coronavirus 2; acute respiratory distress syndrome; coronavirus disease 2019; mechanical ventilation; oxygen therapy; respiratory failure.

Similar articles

See all similar articles

References

    1. The L. COVID-19: Protecting health-care workers. Lancet 2020; 395: 922. - PMC - PubMed
    1. Chang Xu H, Rebaza A, Sharma L, et al. Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med 2020; 8: e13. - PMC - PubMed
    1. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020. Epub ahead of print 28 February 2020. DOI: 10.1056/NEJMoa2002032.
    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China . Lancet 2020; 395: 497–506. - PMC - PubMed
    1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020; 395(10229): 1054–1062. Erratum in: Lancet 28 March 2020; 395(10229): 1038. - PubMed

LinkOut - more resources

Feedback